Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Clorazepate Dipotassium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 7 USDMF, 2 CEP/COS, 1 JDMF, 3 NDC API, 5 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers, 85 FDA Orange Book, 25 Europe, 3 Canada, 1 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 5 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 2 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 3 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 3 Kerry, 8 Microlex e.U, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 8 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders, 15 Direct Compression, 15 Lubricants & Glidants, 14 Disintegrants & Superdisintegrants, 11 Thickeners and Stabilizers, 10 Granulation, 8 Co-Processed Excipients, 7 Controlled & Modified Release, 5 Coating Systems & Additives, 4 Parenteral, 4 Taste Masking, 3 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 2 Film Formers & Plasticizers, 2 API Stability Enhancers, 2 Rheology Modifiers, 1 Topical, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 28 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/10/2024	Sanofi	France	SANOFI SA	4252	CHLORAZEPATE MONOPOTASSIUM	1981-08-10	Inactive	II	N/A
28/10/2024	Taro Pharmaceutical Industries	U.S.A	TARO PHARMACEUTICAL INDUSTRIES LTD	14169	CLORAZEPATE DIPOTASSIUM USP	1999-06-02	Active	II	N/A

Clorazepate Dipotassium

Clorazepate Dipotassium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers

7 USDMF

2 CEP/COS

1 JDMF

3 NDC API

5 Listed Suppliers

$ API Reference Price

INTERMEDIATES

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers

85 FDA Orange Book

25 Europe

3 Canada

1 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 DKSH

1 Jai Radhe Sales

5 Faran Shimi Pharmaceutical

7 Gangwal Healthcare

2 Actylis

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

3 DFE Pharma

1 Finar

5 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

3 Kerry

8 Microlex e.U

1 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

8 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders

15 Direct Compression

15 Lubricants & Glidants

14 Disintegrants & Superdisintegrants

11 Thickeners and Stabilizers

10 Granulation

8 Co-Processed Excipients

7 Controlled & Modified Release

5 Coating Systems & Additives

4 Parenteral

4 Taste Masking

3 Emulsifying Agents

2 Chewable & Orodispersible Aids

2 Film Formers & Plasticizers

2 API Stability Enhancers

2 Rheology Modifiers

1 Topical

1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

28 Finished Drug Prices

MARKET PLACE

2 APIs

REF. STANDARDS & IMPURITIES

3 EDQM

TABLET;ORAL - 11.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 22.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 3.75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons